Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Japanese investigators prepare new agents for influenza

Jan. 5, 2000

Total synthesis, structure reported for antifungal antibiotics produced by Penicillium

Jan. 4, 2000

Miltefosine tested as oral treatment for leishmaniasis

Jan. 4, 2000

ViroPharma licenses Battelle's drug delivery technology for its anti-RSV products

Jan. 3, 2000

Japanese approval obtained for Relenza

Dec. 30, 1999

Vitex receives milestone investment for progress with Inactine

Dec. 30, 1999

Aventis receives first product approval: E.U. grants approval of Synercid

Dec. 29, 1999

BMS presents new water-soluble triazole antifungal prodrugs with superior properties

Dec. 29, 1999

Novel triazole antifungal agents developed in China

Dec. 28, 1999

FK-463, Fujisawa's antifungal agent, in late-stage clinical trials in U.S.

Dec. 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...